Holdings of T. Rowe Price Health Sciences Fund, Inc.
T. ROWE PRICE HEALTH SCIENCES FUND, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 10.9B $ including 10.2B $ in equities, 93.5 %
- Positions
- 168 in 13 countries
- Bond lines
- 1 from 1 company
- Top ten
- 39.4 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Tango Therapeutics Inc | 638,486 | 13.4M $ | 0.12 % |
| 102 | Relay Therapeutics Inc | 1,299,962 | 12.9M $ | 0.12 % |
| 103 | Repligen Corp | 108,730 | 12.8M $ | 0.12 % |
| 104 | Bicara Therapeutics Inc | 642,514 | 12.8M $ | 0.12 % |
| 105 | Cogent Biosciences Inc | 326,181 | 12.6M $ | 0.12 % |
| 106 | Viatris Inc | 927,240 | 12.5M $ | 0.12 % |
| 107 | Tarsus Pharmaceuticals Inc | 175,856 | 12.3M $ | 0.11 % |
| 108 | Ocular Therapeutix Inc | 1,439,766 | 12.2M $ | 0.11 % |
| 109 | Disc Medicine Inc | 186,605 | 11.9M $ | 0.11 % |
| 110 | Tyra Biosciences Inc | 307,082 | 11.8M $ | 0.11 % |
| 111 | Molina Healthcare Inc | 85,655 | 11.4M $ | 0.10 % |
| 112 | Medpace Holdings Inc | 22,932 | 11M $ | 0.10 % |
| 113 | Replimune Group Inc | 1,427,764 | 10.9M $ | 0.10 % |
| 114 | Corvus Pharmaceuticals Inc | 725,099 | 10.6M $ | 0.10 % |
| 115 | Biohaven Ltd | 1,228,554 | 10.4M $ | 0.10 % |
| 116 | Climb Bio Inc | 1,468,417 | 10.1M $ | 0.09 % |
| 117 | Kyverna Therapeutics Inc | 1,142,161 | 9.9M $ | 0.09 % |
| 118 | Liquidia Corp | 260,626 | 9.8M $ | 0.09 % |
| 119 | Cullinan Therapeutics Inc | 686,764 | 9.8M $ | 0.09 % |
| 120 | Olema Pharmaceuticals Inc | 649,181 | 9.7M $ | 0.09 % |
| 121 | Pharvaris NV | 331,529 | 9.4M $ | 0.09 % |
| 122 | Allogene Therapeutics Inc | 3,830,998 | 9.3M $ | 0.09 % |
| 123 | Lantheus Holdings Inc | 122,170 | 9.3M $ | 0.09 % |
| 124 | Denali Therapeutics Inc | 468,129 | 9M $ | 0.08 % |
| 125 | Atrium Therapeutics Inc | 666,325 | 8.9M $ | 0.08 % |
| 126 | Shattuck Labs Inc | 1,366,288 | 8.8M $ | 0.08 % |
| 127 | Ideaya Biosciences Inc | 259,143 | 8.6M $ | 0.08 % |
| 128 | SENSORION SA | 16,950,906 | 8M $ | 0.07 % |
| 129 | SpyGlass Pharma Inc | 290,792 | 7.5M $ | 0.07 % |
| 130 | PROCEPT BIOROBOTICS CORP | 289,633 | 7.2M $ | 0.07 % |
| 131 | Iovance Biotherapeutics Inc | 2,047,047 | 7.2M $ | 0.07 % |
| 132 | Viridian Therapeutics Inc | 343,846 | 6.7M $ | 0.06 % |
| 133 | Alto Neuroscience Inc | 268,280 | 6M $ | 0.06 % |
| 134 | Inspire Medical Systems Inc | 116,160 | 6M $ | 0.06 % |
| 135 | Aktis Oncology Inc | 333,745 | 6M $ | 0.05 % |
| 136 | Evommune Inc | 246,092 | 5.7M $ | 0.05 % |
| 137 | IMMATICS NV | 495,393 | 4.9M $ | 0.04 % |
| 138 | Xencor Inc | 378,576 | 4.6M $ | 0.04 % |
| 139 | Entrada Therapeutics Inc | 329,233 | 4.2M $ | 0.04 % |
| 140 | CRESCENT BIOPHARMA INC | 221,065 | 4.1M $ | 0.04 % |
| 141 | ZAI LAB LTD | 213,174 | 4M $ | 0.04 % |
| 142 | Tectonic Therapeutic Inc | 122,254 | 3.8M $ | 0.03 % |
| 143 | Eikon Therapeutics Inc | 349,098 | 3.7M $ | 0.03 % |
| 144 | Bicycle Therapeutics PLC | 739,251 | 3.4M $ | 0.03 % |
| 145 | Generate Biomedicines Inc | 265,641 | 3.3M $ | 0.03 % |
| 146 | Immuneering Corp | 624,026 | 3.3M $ | 0.03 % |
| 147 | BridgeBio Oncology Therapeutics Inc | 333,485 | 3M $ | 0.03 % |
| 148 | Immix Biopharma Inc | 326,401 | 3M $ | 0.03 % |
| 149 | Agios Pharmaceuticals Inc | 70,221 | 2.4M $ | 0.02 % |
| 150 | SALUDA MEDICAL INC | 3,958,452 | 2.3M $ | 0.02 % |
| 151 | Enliven Therapeutics Inc | 53,863 | 2.1M $ | 0.02 % |
| 152 | Hims & Hers Health Inc | 97,648 | 2M $ | 0.02 % |
| 153 | Immunovant Inc | 81,427 | 2M $ | 0.02 % |
| 154 | Monopar Therapeutics Inc | 34,428 | 1.9M $ | 0.02 % |
| 155 | Rocket Pharmaceuticals Inc | 464,628 | 1.7M $ | 0.02 % |
| 156 | Cabaletta Bio Inc | 608,501 | 1.6M $ | 0.02 % |
| 157 | Adlai Nortye Ltd. | 219,665 | 1.5M $ | 0.01 % |
| 158 | Aura Biosciences Inc | 221,135 | 1.5M $ | 0.01 % |
| 159 | LENZ Therapeutics Inc | 144,751 | 1.3M $ | 0.01 % |
| 160 | Beta Bionics Inc | 113,126 | 1.1M $ | 0.01 % |
| 161 | RadNet Inc | 18,038 | 1M $ | 0.01 % |
| 162 | MediWound Ltd | 62,181 | 1M $ | 0.01 % |
| 163 | Annexon Inc | 176,618 | 978.5K $ | 0.01 % |
| 164 | Nuvation Bio Inc | 186,516 | 800.2K $ | 0.01 % |
| 165 | REVOLUTION MEDICINES INC WTS 12/26 | 198,505 | 345.4K $ | 0.00 % |
| 166 | Janux Therapeutics Inc | 22,599 | 314.1K $ | 0.00 % |
| 167 | Ginkgo Bioworks Holdings Inc | 23,550 | 144.4K $ | 0.00 % |
| 168 | GENEDX HOLDINGS CORP WTS 7/26 | 206,747 | 1.7K $ |
The bonds it holds
1 company, one bond line. Only issuers whose shares this site already serves appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 13.9M $ | 0.13 % |
Sector breakdown
- Health care 68.6 %
- Unattributed 31.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 88.3 %
- United Kingdom 3.4 %
- Netherlands 3.3 %
- Bermuda 1.4 %
- Hong Kong SAR China 1.3 %
- Japan 0.6 %
- Cayman Islands 0.5 %
- France 0.5 %
- Switzerland 0.2 %
- Denmark 0.2 %
- Singapore 0.2 %
- British Virgin Islands 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 148 | 9B $ | 88.34 % |
| 2 | United Kingdom | 2 | 348.8M $ | 3.43 % |
| 3 | Netherlands | 3 | 332.1M $ | 3.26 % |
| 4 | Bermuda | 2 | 138M $ | 1.36 % |
| 5 | Hong Kong SAR China | 1 | 129.2M $ | 1.27 % |
| 6 | Japan | 1 | 62.9M $ | 0.62 % |
| 7 | Cayman Islands | 4 | 55.2M $ | 0.54 % |
| 8 | France | 2 | 53.5M $ | 0.53 % |
| 9 | Switzerland | 1 | 24.1M $ | 0.24 % |
| 10 | Denmark | 1 | 16.4M $ | 0.16 % |
| 11 | Singapore | 1 | 15.3M $ | 0.15 % |
| 12 | British Virgin Islands | 1 | 10.4M $ | 0.10 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Fund, Inc.". https://titelia.com/en/funds/S000002088